Obesity Drug Safety
-
{
- All
- News
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
- Tuesday April 21, 2026
- Health | Written by Sambhav Kumar
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
www.ndtv.com
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
- Tuesday March 24, 2026
- Health | Reported by Tanushka Dutta
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
www.ndtv.com
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
- Monday March 23, 2026
- Health | Written by Shreya Goswami
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
www.ndtv.com
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
- Thursday March 19, 2026
- Health | Written by Sambhav Kumar
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
www.ndtv.com
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
- Tuesday March 17, 2026
- Health | Written by Rupashi Chhabra
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
www.ndtv.com
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
- Wednesday March 11, 2026
- Health | Reported by Tanushka Dutta, Edited by Shreya Goswami
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
www.ndtv.com
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
- Thursday March 5, 2026
- Health | Written by Shreya Goswami
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
www.ndtv.com
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
- Monday February 9, 2026
- Health | Written by Tanushka Dutta
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
www.ndtv.com
-
Ensure Weight Loss Drugs Are Safe, Legal Before Use In 2026: UK Health Agency
- Tuesday December 30, 2025
- Health | Indo-Asian News Service
New Year is the time for many people to pledge reforms in habits and lifestyle, something resorting to drastic measures, but UK's Medicines and Healthcare products Regulatory Agency (MHRA) has urged the people to make sure an
-
www.ndtv.com
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
- Tuesday December 16, 2025
- Health | Written by Debosmita Ghosh
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
www.ndtv.com
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
- Tuesday April 21, 2026
- Health | Written by Sambhav Kumar
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
www.ndtv.com
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
- Tuesday March 24, 2026
- Health | Reported by Tanushka Dutta
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
www.ndtv.com
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
- Monday March 23, 2026
- Health | Written by Shreya Goswami
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
www.ndtv.com
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
- Thursday March 19, 2026
- Health | Written by Sambhav Kumar
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
www.ndtv.com
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
- Tuesday March 17, 2026
- Health | Written by Rupashi Chhabra
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
www.ndtv.com
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
- Wednesday March 11, 2026
- Health | Reported by Tanushka Dutta, Edited by Shreya Goswami
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
www.ndtv.com
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
- Thursday March 5, 2026
- Health | Written by Shreya Goswami
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
www.ndtv.com
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
- Monday February 9, 2026
- Health | Written by Tanushka Dutta
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
www.ndtv.com
-
Ensure Weight Loss Drugs Are Safe, Legal Before Use In 2026: UK Health Agency
- Tuesday December 30, 2025
- Health | Indo-Asian News Service
New Year is the time for many people to pledge reforms in habits and lifestyle, something resorting to drastic measures, but UK's Medicines and Healthcare products Regulatory Agency (MHRA) has urged the people to make sure an
-
www.ndtv.com
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
- Tuesday December 16, 2025
- Health | Written by Debosmita Ghosh
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
www.ndtv.com